Skip to main content
    I

    iBio, Inc. Common Stock (IBIO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.75
    +0.04 (+5.86%)

    Market Cap: $49.79M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    iBio, Inc. Common Stock (IBIO) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    iBio, Inc. Common Stock (IBIO) has a market cap of $49.79M. Its share count is up 1112.74% from a year earlier. It holds $56.40M more cash than debt, 113.26% of its market cap.

    Total Valuation

    Market Cap$49.79M
    Latest price (Nov 17, 2026)$0.75

    Key Dates

    The next earnings report is expected on Feb 8, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 8, 2027 (expected)
    Last Earnings DateNov 10, 2026
    Fiscal Year EndJune

    Share Statistics

    The share count rose 20.65% in the quarter ended Mar 31, 2026 and grew 467.55% a year over 2 years.

    Shares Outstanding104.06M
    Shares Change (YoY)+1112.74%
    Shares Change (QoQ)+20.65%
    Share Count Growth (2Y CAGR)+467.55%

    Valuation Ratios

    Sales and book value multiples are 778.5x and 0.9x. Its year-end P/S ranged from 2.1x to 137.2x from 2016 to 2025.

    P/S Ratio778.5x
    Forward P/S45.8x
    P/B Ratio0.9x
    P/TBV Ratio0.9x

    Valuation history and multiples

    Price Statistics

    The stock is down 35.51% over 52 weeks and trades 21.88% below its 50-day average.

    Beta (1Y)2.25
    52-Week Change-35.51%
    1-Month Change-1.58%
    3-Month Change-49.79%
    6-Month Change-50.13%
    5-Year Change-99.80%
    10-Year Change-99.97%
    Total Return (1Y)-35.51%
    Total Return (3Y CAGR)-47.61%
    Total Return (5Y CAGR)-70.44%
    Max Drawdown (1Y)-76.98%
    Max Drawdown (3Y)-91.06%
    Sharpe Ratio (1Y)-0.48
    Correlation with SPY (1Y)0.31
    50-Day Average$0.96
    200-Day Average$1.61
    52-Week Range$0.68 to $3.82
    RSI (14 Days)42.0
    Average Volume (20 Days)433.77K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 7.85x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio7.85x
    Quick Ratio7.85x
    Debt / Equity0.00x
    Interest Coverage-663.04x

    Returns and Efficiency

    Return on equity is -38.55% and return on assets is -33.34% over the last 12 months.

    Return on Equity (ROE)-38.55%
    Return on Assets (ROA)-33.34%
    ROA (5Y Average)-81.53%
    ROIC (5Y Average)-65.28%

    Scores

    IBIO has an Altman Z-Score of -1.87, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score-1.87
    Altman Z ZoneDistress
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Operating Income-$35.14M
    Pretax Income-$33.04M
    Net Income-$33.04M
    Reported EPS (TTM)-$0.24

    Trailing 12 months through Jun 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 86.48% of the $99.11M in total assets.

    Cash and Equivalents$56.40M
    Total Debt$0
    Net Cash$56.40M
    Net Cash Per Share$0.54
    Working Capital$80.48M
    Shareholder Equity$85.71M
    Book Value Per Share$0.82
    Tangible Book Value$83.89M
    Tangible Book Per Share$0.81
    Total Assets$99.11M
    Total Liabilities$13.40M

    Balance sheet as of Jun 30, 2026.

    Full balance sheet

    Cash Flow

    After $578.00K of capital spending, operating cash flow left -$23.80M of free cash flow.

    Operating Cash Flow-$23.22M
    Capital Expenditures$578.00K
    Free Cash Flow-$23.80M
    FCF Per Share-$0.37
    Depreciation and Amortization$992.00K

    Trailing 12 months through Jun 30, 2026.

    Full cash flow statement

    Dividends and Yields

    IBIO does not pay a dividend. Its free cash flow yield is -30.57%.

    FCF Yield-30.57%
    Buyback Yield-114.71%
    Shareholder Yield-114.71%

    Stock Splits

    The last split was a 1-for-20 reverse split on Nov 29, 2023.

    Last Split DateNov 29, 2023
    Split TypeReverse split
    Split Ratio1:20

    Analyst Forecast

    Consensus estimates put revenue growth at 65.83% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+65.83%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About IBIO

    What is IBIO's market cap?

    iBio, Inc. Common Stock has a market cap of $49.79M.

    How many shares of IBIO are outstanding?

    iBio, Inc. Common Stock has 104.06M shares outstanding. The count is up 1112.74% from a year earlier.

    Does IBIO pay a dividend?

    No. iBio, Inc. Common Stock does not pay a dividend.

    How much debt does IBIO have?

    iBio, Inc. Common Stock has $0 of total debt and $56.40M of cash and equivalents, a net cash position of $56.40M.